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Abstract
Merosin deficient congenital muscular dystrophy (MDC1A) is a severe neuromuscular disor-
der with onset in infancy that is associated with severe morbidities (particularly wheelchair
dependence) and early mortality. It is caused by recessive mutations in the LAMA2 gene
that encodes a subunit of the extracellular matrix protein laminin 211. At present, there are
no treatments for this disabling disease. The zebrafish has emerged as a powerful model
system for the identification of novel therapies. However, drug discovery in the zebrafish is
largely dependent on the identification of phenotypes suitable for chemical screening. Our
goal in this study was to elucidate novel, early onset abnormalities in the candyfloss (caf)
zebrafish, a model of MDC1A. We uncovered and characterize abnormalities in spontane-
ous coiling, the earliest motor movement in the zebrafish, as a fully penetrant change spe-
cific to caf mutants that is ideal for future drug testing.
Introduction
Merosin deficient congenital muscular dystrophy (or MDC1A) is a severe muscle disease that
is estimated to affect between one to nine-thousand births worldwide, and is the most preva-
lent CMD in Western countries[1,2]. It is an autosomal recessive disorder caused by mutations
in LAMA2, the gene that codes for the laminin-α2 protein (formerly known as merosin)[3–6].
Laminins are heterotrimeric extracellular adhesion molecules composed of an α-chain, β-
chain, and γ-chain and are temporally and spatially expressed in the basement membranes sur-
rounding various cell types. In skeletal muscle, the laminin-211 isoform (composed of lami-
nins α-2, β-1 and γ-1) predominates[7] and is one of the critical proteins that participates in
anchoring the inner actin cytoskeleton to the extracellular matrix (ECM)[8]. Mutations in
LAMA2 result in either a complete absence or severe reduction of laminin-211, which threat-
ens the integrity of the skeletal muscle fiber, ultimately leading to muscle degeneration and cell
death.
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MDC1A is a clinically devastating disease characterized by severe hypotonia, muscle weak-
ness, elevated creatine phosphokinase levels, joint contractures, white matter abnormalities,
and delayed motor milestones, with symptoms presenting at or shortly after birth [9,10]. Less
than one quarter of patients achieve independent ambulation [11], and complications include
scoliosis, feeding difficulties, wheelchair dependence, and premature mortality: 30 percent of
patients die within their first decade of life, most commonly due to respiratory tract infection
[2,9]. As there are no curative or significant disease modifying therapies for MDC1A, there is a
critical need to identify potential treatments to improve the quality of life of patients with the
ultimate goal of curing the disease.
Danio rerio (zebrafish) has emerged as an excellent model for the study of human muscle
disease [12]. Due to the high fecundity of zebrafish and the rapid ex utero development and
optical transparency of developing embryos, the zebrafish lends itself to large-scale phenotypic
screens of chemical libraries and is thus an ideal model organism for therapy development
[13,14]. One of the keys to successful drug discovery in a model organism is identifying suit-
able phenotypes for compound testing. In the candyfloss (caf) [15] model, muscle fibers begin
detaching and degenerating at 36 hpf, but visualizing this phenotype requires confocal micros-
copy until approximately 2 dpf when muscle damage can be viewed under plane polarized
light as a reduction or absence of birefringence [16]. In this study, we sought to determine
whether we could identify a new phenotype that would allow for earlier detection of caf
mutants, prior to the onset of muscle fiber detachment. Because MDC1A is a muscle disease,
we looked at the earliest skeletal movement performed by developing embryos: spontaneous
coiling. Zebrafish embryos begin to coil spontaneously at 17 hpf and by 21 hpf, they begin to
coil in response to touch [17]. We found that as early as 23 hpf, caf mutants have a defect in
their coiling abilities after manual dechorionation, which we believe could be exploited as an
early phenotypic marker of mutants in large-scale drug screens. Moreover, a coiling defect was
not observed in the zebrafish model of Duchenne muscular dystrophy, sapje [18], suggesting
that this phenotype is not common to all zebrafish models of muscular dystrophies.
Materials and methods
Zebrafish husbandry
Heterozygous (lama2+/-) candyfloss (caf) and sapje (sap) zebrafish were obtained from the Uni-
versity of Tu¨bingen. Both strains are housed and bred in adherence to zebrafish husbandry
protocols approved by the Animal Care Committee at the Peter Gilgan Centre for Research
and Learning at the Hospital for Sick Children, including specific IACUC approval for
the experimentation described in this study (protocol number 29161). All procedures for
lama2cl501 fish line were approved from the Harvard University Institutional Animal Care and
Use Committee (2016N000304).
Coiling assay
Embryos from heterozygous matings were collected at 1 hpf and incubated at 28.5˚C in system
water with methylene blue. At 22 hpf, embryos from all clutches were pooled. At the desig-
nated time point (22 23, or 24 hpf), embryos were removed from incubation and their coils
were counted either for 15 seconds immediately after dechorionation with forceps or for 30
seconds while remaining in their chorions. Embryos were viewed using an Olympus SZX7
microscope. A full coil was determined to be where the embryo’s tail was able to completely
curve around its trunk and touch its head. A partial coil was determined to be when an embryo
made the movement to complete a coil, but was unable to. After the coils of an embryo
counted, it was placed into an individual well of a 24-well plate filled with system water with
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methylene blue (egg water) and was incubated at 28.5˚C until 3 dpf (cafs) or 5 dpf (sapje) upon
which the genotypes were confirmed with birefringence.
Birefringence
Birefringence was observed by light microscopy using a plane-polarizing filter on an Olympus
SZX7 microscope.
Statistical analysis
All statistical analyses (student T-test and two-way ANOVA) were completed with Prism 6.0.
Results
Defining spontaneous coiling parameters in caf zebrafish
This study began when we noticed that qualitatively, we were able to predict caf mutants based
on how often they coiled after manual dechorionation at 24 hours post fertilization (hpf). This
led us to design a protocol that would allow for quantitatively measuring the number of coils
performed by caf (lama2-/-)embryos and their wild type (WT) siblings in a short time period
(15 or 30 seconds). Heterozygous (lama2+/-) zebrafish were mated and embryos were pooled
at 22 hpf. At this time point, we were unable to visualize (using birefringence analysis) any
muscle fiber detachment and could not visually distinguish caf mutants apart from their WT
(lama2+/- and lama2+/+) siblings. At 22, 23, and 24 hpf, we counted the number of full coils
completed by each embryo within the 15 seconds immediately after manual dechorionation
with forceps, or in 30 second period with no dechorionation (i.e. embryos remaining in their
chorions). We doubled the time for counting coils when the embryos remained in their chori-
ons because we predicted (based on previous work) that the embryos complete fewer coils if
not mechanically stimulated [17]. We determined a full coil to be where the end of an embryo’s
trunk was able to curl around and touch its head (Fig 1A). After the coils of an embryo were
counted, the embryo was placed into an individual well of a 24-well plate and the embryos
developed until a time point where their genotype (caf or WT sibling) could be determined
with birefringence (Fig 2). Of note, there is complete correspondence between abnormal bire-
fringence and the caf genotype. Additionally, in a subset of embryos (n = 40), genotypes were
validated by genetic analysis.
Caf mutants complete significantly less coils than WT siblings after
manual dechorionation
In embryos derived from a heterozygous (lama2+/- x lama2+/-) mating pair confined in their
chorions, we found that there was no significant difference in the coiling abilities of WT sib-
lings and caf mutants at any time point (22, 23, and 24 hpf); all embryos would complete
approximately one coil within a 30-second time period (Fig 1B). While it is possible that cafs
and WTs would differ in coiling in their chorions if examined for longer time periods, we did
not further investigate this possibility because we were interested in identifying phenotypes
suitable for large-scale drug screening.
It has been shown that zebrafish embryos vigorously coil in response to touch starting at 21
hpf [17,19]; therefore, we reasoned that stimulating the embryos with manual dechorionation
would increase the number of coils they complete, making it more feasible to identify mutants.
At 22 hpf, we found that there was no significant difference in the coiling abilities of WT sibs
and caf mutants upon manual dechorionation. However, we observed that caf mutants com-
plete significantly fewer coils than their WT siblings at 23 and 24 hpf (Fig 1C) (S1 and S2
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Videos). Furthermore, there is no significant difference in the coiling abilities of lama2+/- WT
embryos (i.e. heterozygotes) compared to lama2+/+ WTs, and caf mutants complete signifi-
cantly less coils than both groups (Fig 3). This novel coiling discrepancy of caf mutants pres-
ents us with an easily measurable phenotype that has previously never been reported, and thus
a protocol that can be easily optimized to act as a read-out in high-throughput drug screens.
The lama2cl501 line also displays a coiling defect
To validate our observation, we examined another zebrafish line that models merosin deficient
congenital muscular dystrophy. This line, lama2cl501, was identified from an ENU screen [20].
It carries a splice site mutation in lama2 and produces a phenotype indistinguishable from caf.
Fig 1. Caf mutants display a coiling phenotype as early as 23 hpf. A) One full coil completed by a 24 hpf wild type (lama2+/+ and lama2+/-; WT)
zebrafish embryo. B) Number of coils of WT siblings and caf (lama2-/-) mutants over 30 seconds when left in their chorions. There is no significant
difference in the coiling abilities of caf mutants and their WT siblings at 22 hpf (WT sibs: 1.071 ± 0.3391, n = 14; cafs: 1.000 ± 0.7071, n = 4; p>0.9999), 23
hpf (WT sibs: 0.9286 ±0.3987, n = 14; cafs: 1.000 ± 1.000, n = 2; p>0.9999) or 24 hpf (WT sibs: 1.133 ± 0.2906, n = 15; cafs: 1.222 ± 0.3643, n = 9;
p>0.9999). C) Number of coils of WT siblings and caf mutants in the 15 seconds immediately after manual dechorionation. At 22 hpf, there was no
significant difference in number of coils completed by WT siblings and caf mutants (WT sibs: 3.654 ± 0.7685, n = 26; cafs: 3.250 ± 1.031, n = 8; p>0.9999).
However, cafs completed significantly less coils than their WT sibs at 23 hpf (WT sibs: 7.444 ± 0.5587, n = 72; cafs: 3.476 ± 0.5921, n = 21; p = 0.0194) and
24 hpf (WT sibs: 10.71 ± 0.4436, n = 163; cafs: 2.936 ± 0.6646, n = 47; p<0.0001). Bars represent mean ± SEM.
doi:10.1371/journal.pone.0172648.g001
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Using similar methodology that described above, we measured coiling, both in the chorion
and upon dechorionating, at 22, 23, and 24 hpf. As with the caf mutants, lama2cl501 mutants
also displayed a significant defect in spontaneous coiling that was present at 23 hpf and 24 hpf
(S1 Table and S1 Fig). This independent observation supports our conclusion that the coiling
defect we observe is due to the lama2 mutation.
Fig 2. Muscle fiber detachment of caf mutants can be observed with birefringence. Under plane
polarized light, muscle from WT siblings (A) appears uniformly bright and white, consistent with normal
muscle organization. In contrast, Caf mutants (B-F_ can be identified as having stochastic patterns of muscle
degeneration and detachment with birefringence as early as 2 dpf. This is seen in the muscle compartment as
dim white areas (thinned or atrophied fibers) and black spots (presumed areas of muscle fiber detachment).
Of note, genotype for all depicted animals was confirmed by Sanger sequencing. Bars represent mean ± SEM.
doi:10.1371/journal.pone.0172648.g002
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The coiling defect of caf mutants is due likely due to muscular
abnormalities
The coiling of zebrafish embryos in response to touch requires input from both nervous and
muscular systems in order to bring about functional motor behavior [19]. As it has been well
established that there are white matter abnormalities in MDC1A patients, the coiling discrep-
ancy could be due to defects in both neurological and/or muscular systems. We reasoned that
if the coiling defect observed in caf mutants was due to ultrastructural abnormalities in skeletal
muscle alone, the cafs would at least initiate a coil as many times as their WT sibling counter-
parts. To investigate this, we counted the number of full and partial coils made by caf mutants
compared that to the number of full and partial coils completed by WT siblings. We counted
any attempt to coil that did not result in a complete coil as a partial coil. We found that there
was no significant difference in the number of total coils (full and partial) attempted by caf
mutants compared to WT siblings, indicating that impaired neuronal input is unlikely to be
the cause of the abnormal coiling phenotype (Fig 4). This is perhaps unsurprising, as innerva-
tion in caf zebrafish was previously reported to be normal [15]. As such, we believe that the
coiling phenotype of caf mutants is due to primary defects in muscle fibers that have yet to be
elucidated.
Abnormal filamentous actin distribution supports an early muscle defect
in caf embryos
Our observation of disrupted full coils in 24 hpf dechorionated caf embryos suggests that
mutant skeletal muscle may be abnormal at this early stage of muscle development. To investi-
gate this further, we utilized phalloidin staining as a means of detecting changes in myofiber
organization. Phalloidin highlights filamentous actin and has been used by others as a means
of documenting abnormalities in dystrophic muscle of various zebrafish models. Wild type
embryos at 24 hpf showed the expected pattern of phalloidin staining (n = 5). Caf embryos, in
Fig 3. Heterozygous lama2+/- embryos have no coiling deficiency. Heterozygous (lama2+/-) embryos do
not display any coiling deficiency compared to their lama2+/+ WT siblings at 24 hpf after manual dechorionation
(WT: 13.20 ± 2.037, n = 10; Het: 11.80 ± 1.654, n = 15; p = 0.5984). Bars represent mean ± SEM.
doi:10.1371/journal.pone.0172648.g003
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contrast, displayed altered expression, with intense staining detected at a location consistent
with the myotendinous junction (n = 5) (Fig 5). While the full significance of this observation
merits further investigation, these data further support an early skeletal muscle phenotype in
caf mutants.
Coiling deficiency is not common to all zebrafish models of muscular
dystrophy
Because of the significant difference in the coiling abilities of caf mutants compared to their
WT siblings, we went on to determine whether this phenotype is unique to caf mutants by
Fig 4. Caf mutants attempt to coil as often as their WT siblings. There is no significant difference
between the number of full coils and the number of full and partial coils completed by WT sibs, indicating that
nearly all of the coiling attempts completed by WT sibs result in a full coil (WT Sibs (full coils): 11.86 ± 0.7253,
n = 44; WT Sibs (full and partial coils): 12.02 ±0.6962, n = 44; p = 0.9975). As expected, cafs perform
significantly less full coils (1.917 ± 0.7633, n = 12) compared to the number of full coils completed by WT sibs
(p<0.0001) and the number of full and partial coils completed by WT sibs (p<0.0001). However, when the
number of partial coiling attempts by caf mutants is combined with their full coils (9.083 ± 1.158, n = 12), their
coiling attempts are restored to WT levels when compared to WT full coils (p = 0.2084) and WT full and partial
coils (p = 0.1633). Bars represent mean ± SEM.
doi:10.1371/journal.pone.0172648.g004
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examining whether the zebrafish model of Duchenne muscular dystrophy, sapje, had similar
defects. Because the spontaneous coiling of caf mutants in their chorions was not predictive of
their genotype, we only examined the number of coils completed by sapje mutants after man-
ual dechorionation. At both 23 and 24 hpf, we found that sapje mutants had a similar number
of full coils as compared to wild type (Fig 6), indicating that not all zebrafish models of muscu-
lar dystrophies a coiling phenotype and suggesting that this phenotype may be unique to caf
mutants.
Discussion
In this study, we have further characterized the zebrafish model of MDC1A, candyfloss (caf),
by identifying a novel coiling phenotype. Prior to this study, the first reported pathology of caf
mutants was slow muscle fiber degeneration at 36 hpf [15]. Here, we have observed a defect in
the ability of caf mutants to complete full coils, which is mediated primarily by slow muscle
fibers [19], as early as 23 hpf, long before the onset of muscle detachment and degeneration.
This observation suggests that although the fibers differentiate appropriately and appear nor-
mal prior to 36 hpf [15], there may be abnormalities in the muscle that are impairing the ability
of the caf mutants to properly coil, an assertion supported by our demonstration of abnormal
distribution of filamentous actin in 24 hpf myofibers. Furthermore, we did not observe this
phenotype in a zebrafish model of Duchenne muscular dystrophy, sapje, indicating that this
Fig 5. Abnormal phalloidin staining in skeletal muscle from caf mutant embryos. Wild type (WT) and
caf mutants were staining with phalloidin to illuminate filamentous actin and then visualized whole mount by
confocal microscopy. (A) WTs show the expected pattern of staining at 24 hpf (n = 5). (B) In muscle from caf
mutants, there is an accumulation of intense staining in the region of the myotendinous junction (arrow)
(n = 5). Scale bar = 10 um.
doi:10.1371/journal.pone.0172648.g005
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phenotype is not common to all zebrafish models of muscular dystrophy and may be unique
to caf mutants.
In MDC1A patients, disease symptoms present either at or shortly after birth, and it is spec-
ulated that these patients are never truly pre-symptomatic. In contrast, the onset of Duchenne
muscular dystrophy is later, where boys begin developing symptoms between 1.5–2.5 years of
age. The reason as to why MDC1A is a congenital muscle disease is incompletely understood.
Mehuron et al identified early perinatal pathology in a mouse model of MDC1A, and corre-
lated this with increases in apoptosis during myogenesis [21]. Our findings of a coiling defect
in caf mutants are consistent with the congenital symptoms seen in both patients and mice
with MDC1A, and they open an avenue for further exploration of the mechanisms underlying
the early-onset phenotype.
Importantly, the phenotype we have identified, because of the ease in its identification and the
ability to automate the analysis using recording systems such as the Viewpoint Zebrabox, can be
exploited for large-scale drug screens. This phenotype holds advantages over birefringence, the
tool most commonly used for drug development in dystrophic models. One advantage is that the
early coiling phenotype occurs prior to muscle detachment, and thus may represent a treatment
window period. It is reasonable to speculate that, at least in zebrafish, fully detached muscle will
be difficult to “fix” with chemical modification, and thus limit the opportunity for finding drug
targets using this model. Additionally, using the coiling phenotype as a measure of therapeutic
effectiveness rather than the dystrophic phenotype, which is fully penetrant at 3 dpf [15], is a
more cost-effective approach, as less chemicals would be required over time.
Fig 6. Coiling deficiency is not observed in the zebrafish model of Duchenne muscular dystrophy.
Sapje mutants, the zebrafish model of Duchenne muscular dystrophy, do not present with a coiling phenotype
at 23 hpf (WT sibs: 6.823 ± 0.4642, n = 62; cafs: 5.000 ± 0.9244, n = 11; p = 0.1088) or 24 hpf (WT sibs:
7.347 ± 0.4950, n = 72; cafs: 8.063 ± 1.066, n = 16; p = 0.9997). Bars represent mean ± SEM.
doi:10.1371/journal.pone.0172648.g006
New phenotype of zebrafish model of MDC1A
PLOS ONE | DOI:10.1371/journal.pone.0172648 February 27, 2017 9 / 12
In conclusion, we have identified a novel coiling phenotype of caf mutants suitable for use in
high-throughput drug screens that may serve as a measure of therapeutic effectiveness by har-
nessing the power of automated movement-tracking systems such as the Zebrabox platform
(Viewpoint) or Noldus. This strengthens the characterization of the caf zebrafish model of
MDC1A and lays the foundation for further experiments that aim to understand the mecha-
nisms that result in stochastic muscle fiber degeneration in MDC1A and other congenital mus-
cular dystrophies.
Supporting information
S1 Table. Coiling in the lama2cl501 zebrafish model of MDC1A. 1. Number of coils in the
chorion, wild type versus lama2cl501mutants. There was no statistical difference in coiling
behavior between the two groups when embryos remained in their chorions. 2. Number of
coils for dechorionated embryos, wild type versus lama2cl501 mutants. There was a statistically
significant decrease in coiling by lama2cl501 mutants in embryos dechorionated at 24 hours
post fertilization but not at time points before this.
(DOCX)
S1 Fig. lama2cl501 mutants have reduced coiling upon dechorionation. Still images from
time lapse videos of wild type clutchmates (control) and lama2cl501 (lama2) mutants at 24
hours post fertilization. Videos were taken just after dechorionation. Lama2 mutants demon-
strate only partial coiling and do not complete a normal/full coiling in the 2 second period
shown. In contrast, the control embryo completes 2 full coils.
(DOCX)
S1 Video. Spontaneous coiling of a dechorionated wild type embryo at 24 hours post fertil-
ization.
(MOV)
S2 Video. Spontaneous coiling of a dechorionated caf embryo at 24 hours post fertilization.
(MOV)
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